NLS Pharmaceutics Ltd.

About NLS Pharmaceutics Ltd.

NLS Pharmaceutics is dedicated to redefining therapies for central nervous system (CNS) disorders. Founded in 2015, their mission is to safeguard life and longevity by empowering the brain through all stages of life. They focus on developing safe, effective, and better-tolerated drugs to improve mental and behavioral disorders, addressing conditions like narcolepsy and ADHD, which affect millions globally.

Products & Services

Central Nervous System (CNS) Therapies: Drugs and treatments aimed at improving mental and behavioral disorders such as narcolepsy and ADHD.

Specialties

Central Nervous System (CNS) Disorders Narcolepsy Treatment ADHD Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity T: - FT: Equity	A: 1000000 MR: - FA: $1 Million FAN: 1000000	D: 2025-06-30 FD: 2025-06-30	-
2	RT: Equity Financing T: - FT: Equity Financing	A: 2000000 MR: - FA: $2 million (with potential additional $1 million) FAN: 2000000	D: 2025-03-28 FD: 2025-03-28	-
3	RT: Equity Financing T: - FT: Equity Financing	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2025-01-08 FD: 2025-01-08	1 investors
4	RT: Private Placement T: - FT: Private Placement	A: 1000000 MR: - FA: up to $1.0 million FAN: 1000000	D: 2024-12-04 FD: 2024-12-04	-
5	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 786660 MR: - FA: $786,660 FAN: 786660	D: 2024-06-28 FD: 2024-06-28	1 investors
6	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 1750000 MR: - FA: 1.75 million FAN: 1750000	D: 2024-03-22 FD: 2024-03-22	1 investors
7	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 1750000 MR: - FA: $1.75 million FAN: 1750000	D: 2024-03-20 FD: 2024-03-20	-

Equity Latest

2025-06-30

$1.0M

Equity Financing 2025-03-28

$2.0M

Equity Financing 2025-01-08

$500K

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alexander Zwyer

Chief Executive Officer & Co-Founder

LinkedIn (Pro only)

E

Eric Konofal

Chief Scientific Officer and Co-Founder

N

Nicole Fernandez

Chief Financial Officer

R

Ronald Hafner

Chairman of the Board of Directors

G

Gian-Marco Rinaldi

Has over 25 years of experience in the financial industry

A

Audrey Greenberg

Co-founder, Executive Managing Director and Board Member of the Discovery Labs Center for Breakthrough Medicines

View 6 more team members with Pro

Unlock Full Team Directory

Recent News